Get started
Why AIrBNB might be the company to watch in 2025Hello, we see an opportunity for investors to buy Airbnb at the bottom. In this video we go a step further and try and explain why. While the company's long-term prospects remain strong, short-term headwinds are likely to keep its stock price under pressure. As the travel industry gradually normalizes post-COVID, we anticipate minimal demand erosion for alternative accommodations from ABNB's existing customer base. However, the company's share growth in urban markets continues to lag behind its gains in non-urban regions in recent years, presenting a potential growth opportunity moving forward. In the near term, I anticipate AirBNB's share price will continue its pullback to around USD 100. However, over the longer term, the company is expected to remain resilient, with an initial price target of USD 170 and a longer-term target of USD 220.88. All the best & goodluck
NASDAQ:ABNBLong
by thesharkke
$TSLA Trade Analysis DarkPoolsOverview of Chart The updated chart for TSLA shows additional volume information, key pivot levels (R1, R2, R3, P, and S1), and dark pool prints, which provide a clearer picture of institutional activity and support/resistance zones. The chart continues to reflect the stock's bullish trend but highlights a potential consolidation phase around critical resistance. Key Observations Trend Continuation with Consolidation: TSLA remains in an uptrend, with the price still above the 8 EMA (white line), which acts as a short-term dynamic support. However, the current candles indicate consolidation near the R2 pivot level ($443.60), where selling pressure is evident. Dark Pool Prints and Institutional Activity: The dark pool print at $436.17 (1.6M shares) remains a critical support level. This suggests institutional interest in this price area, likely acting as a floor for further pullbacks. Holding above this level confirms bullish sentiment. A failure to hold this level could accelerate a bearish pullback toward lower pivot levels. Volume Analysis: The chart now shows elevated volume on recent red candles, which suggests increased selling pressure near resistance levels. Notably, the volume spike is not overwhelmingly bearish, indicating potential profit-taking rather than a complete reversal of the trend. Pivot Levels and Support/Resistance Zones: Immediate Resistance: The R2 pivot ($443.60) is acting as a ceiling for TSLA's recent upward momentum. Breaking this level could result in a move toward R3 ($514.82). Immediate Support: The dark pool level ($436.17) and the 8 EMA align as immediate support levels. Below this, the R1 pivot ($391.77) and 21 EMA ($393.86) represent the next significant supports. Bearish Divergence Risk: While the overall trend is bullish, the consolidation near R2 and elevated selling volume suggest a potential pullback if support levels fail to hold. Trade Plan Bullish Scenario: Entry: A confirmed breakout above the R2 pivot ($443.60) with increasing volume. Ideally, a daily close above this level will confirm the breakout. Targets: First Target (T1): $456 (recent swing high). Second Target (T2): $514.82 (R3 pivot). Stop Loss: Below the dark pool level ($436.17). Bearish Scenario: Entry: If TSLA closes below $436.17 and the 8 EMA, indicating a loss of short-term bullish momentum. Targets: First Target (T1): $413 (pivot support). Second Target (T2): $393.86 (21 EMA). Stop Loss: Above the R2 pivot ($443.60). Additional Considerations Risk Management: TSLA is volatile, and trades should consider position sizing and stop-loss placement to manage risk effectively. Monitor the overall market sentiment (e.g., SPY, QQQ) for confirmation of broader trends. Institutional Influence: Keep an eye on how the price reacts to the dark pool print at $436.17. Institutional support or rejection here will guide the next move. Broader Market Factors: Tesla's price can be influenced by sector-wide news (e.g., EV market trends) and macroeconomic factors (e.g., interest rates or broader tech sentiment).
NASDAQ:TSLAShort
by thedarkpooltrader
4
$IONQ in bullish price discovery. Key Stats: Market Cap: Approximately $9.61 billion Revenue (TTM): $22.04 million Next Earnings Date: March 26, 2025 Technical Reasons for Bullish Outlook: Strong Upward Momentum: IONQ has been on a tear, with a 17.64% increase in the past 24 hours, pushing the stock to a new 52-week high. Bullish Moving Averages: The stock is trading well above its 20-day (34.82), 50-day (27.30), and 100-day (20.67) exponential moving averages, indicating sustained upward momentum. Positive Price Rate of Change (ROC): With a ROC of 38.55, IONQ is exhibiting strong price appreciation, signalling continued bullish sentiment. Fundamental Reasons for Bullish Outlook: Analyst Upgrades: Craig Hallum recently raised their target price for IonQ from $22.00 to $45.00, maintaining a “buy” rating, reflecting increased confidence in the company's prospects. Strong Growth Potential: IonQ is a leader in quantum computing, a field poised for significant growth, positioning the company to capitalize on emerging technological advancements. Solid Financial Position: Despite current earnings losses, IonQ's substantial market cap and revenue growth indicate robust investor confidence and potential for future profitability. Potential Paths to Profit: Option 1: Buy Shares (Lowest Risk) Option 2: Buy LEAP Options expiring in 8-12 months, and sell when the stock approaches your profit target. Disclaimer: We are not a brokerage or investment firm. We do not offer financial advice or investment advice and/or signals. This is not certified financial education. We offer access to the daily thought process of an individual and his experiences. We do not offer refunds. All sales are final. Please LIKE, FOLLOW, SHARE, and COMMENT if you enjoy this idea! Also, share your ideas and charts in the comments section below! This is the best way to keep this signal relevant, keep the content free, and allow the idea to reach as many people as possible.
NYSE:IONQLong
by ChartVZN
Tesla Q4 2024 Deliveries Expected to Hit Record, but.Tesla's fourth-quarter 2024 delivery figures are anticipated to reach a record high, according to a note from Barclays. Analysts estimate Q4 deliveries at approximately 515,000 units, slightly above the consensus estimate of around 511,000 units, marking a 6% year-over-year increase. Despite these impressive numbers, Barclays believes they will have limited impact on Tesla's stock. Key Takeaways: Delivery Estimates: Barclays projects Q4 deliveries to be around 515,000 units, slightly exceeding expectations. Stock Impact: The delivery numbers are expected to have minimal influence on Tesla's stock, as investors are more focused on the company's long-term opportunities in autonomous driving and artificial intelligence (AI). Long-Term Growth: Tesla's recent momentum is driven by its potential in the AV/AI sectors rather than short-term delivery metrics. Future Outlook: 2024 Sales: Barclays forecasts Tesla's full-year 2024 sales at approximately 1.81 million units, aligning with 2023 figures but falling short of the company's guidance for year-over-year growth. Autonomous Driving and AI: The introduction of "Unsupervised Full Self-Driving" (FSD) in 2025 is expected to bolster Tesla's AV/AI initiatives, mitigating any near-term volume misses. New Models: The upcoming low-cost model, "Model 2.5," anticipated in the first half of 2025, is seen as a crucial growth driver. Delivery Growth: CEO Elon Musk suggests 20-30% year-over-year delivery growth in 2025, which Barclays believes will address any concerns from the Q4 figures. Barclays emphasizes that while the Q4 results are crucial, the stock's recent rally—up 68% post-election versus the S&P 500's 2.6%—reflects positive sentiment on Tesla's long-term potential and technical factors. As the market shifts focus towards future developments, the emphasis remains on Tesla's ability to innovate and lead in the autonomous driving and AI sectors.
NASDAQ:TSLA
by OakleyJM
BPTH could be in for a bull market in 2025!One new low cap stock pick with my research described below, please do your own research aswell and remember these are risky moves - thus small allocation. I will be back with many crypto charts for next year as well, don't worry! Bio-Path Holdings (BPTH) Overview: Bio-Path Holdings, Inc. is a biotechnology company focused on developing nucleic acid cancer drugs using its proprietary DNAbilize antisense RNAi nanoparticle technology. This technology allows for the development of drugs that can be administered through intravenous transfusion, targeting specific genes associated with cancer. Last week, Bio-Path Holdings announced preclinical results for their drug candidate BP1001-A. The study demonstrated that BP1001-A enhances insulin sensitivity, suggesting its potential as a treatment for obesity in patients with Type 2 diabetes. In 2025, Bio-Path Holdings plans to initiate a first-in-human Phase 1 clinical trial for BP1001-A, focusing on validating its safety, measuring pharmacokinetics, and establishing dosing for potential pivotal trials. This trial is aimed at further exploring BP1001-A's potential as a treatment for obesity and related metabolic diseases in patients with Type 2 diabetes. A successful trial would likely lead to a significant increase in Bio-Path Holdings' stock price. The news of positive clinical results would be seen as a validation of the drug's potential, attracting more investor interest and possibly leading to partnerships or buyouts from larger pharmaceutical companies. SPECULATION: Estimating the yearly revenue potential and a fair valuation for Bio-Path Holdings (BPTH) based on BP1001-A's market entry involves several speculative assumptions, as we lack specific data on market penetration, pricing, competition, and long-term efficacy. Here's a theoretical breakdown: Revenue Potential: Market Size and Share: Obesity and Type 2 Diabetes Market: The global market for treatments of obesity and Type 2 diabetes is substantial. For context, the global diabetes market alone was valued at approximately $51.1 billion in 2022, expected to reach $81.6 billion by 2030, growing at a CAGR of around 6.5% (). However, BP1001-A would be competing in a segment of this market focused on novel treatments or those with a unique mechanism like insulin sensitivity enhancement. Assumed Market Share: Assuming BP1001-A captures a niche segment, let's speculate it achieves a 1% to 5% market share due to its novel mode of action and targeting a specific subset of Type 2 diabetes patients with obesity. Pricing and Usage: Drug Pricing: New diabetes drugs, especially those with innovative mechanisms, can be priced high. For instance, if we assume a yearly cost per patient of $10,000 (considering the high cost of biologics and similar therapies), Patient Population: If we estimate that 1% of the diabetic population globally (approximately 537 million adults in 2021 according to IDF) could benefit from this drug, that's about 5.37 million patients. At 5% market share, this would mean 268,500 patients. Revenue Calculation: Annual Revenue: If 268,500 patients use BP1001-A at $10,000 per year, the potential annual revenue would be approximately $2.685 billion. For a 1% market share (53,700 patients), it would be around $537 million. Valuation: DCF Approach: A Discounted Cash Flow (DCF) analysis would be the traditional method to value BPTH if BP1001-A were to generate such revenues. Here's a simplified speculative approach: Cash Flow: Assuming 50% of revenue translates into gross profit (considering R&D, marketing, and other costs), a 1% market share would yield $268.5 million in gross profit, and 5% would yield $1.3425 billion. Discount Rate: Biotech companies often have high discount rates due to risk. Let's assume a 15% discount rate for this speculative valuation. Growth & Terminal Value: Assume growth stabilizes after initial high growth years, with a terminal growth rate of 2% post-patent exclusivity period (which might be around 20 years from patent to market). Valuation Calculation: With a 1% market share scenario: Present Value of Cash Flows for first 10 years (assuming rapid growth then stabilization): $268.5M * Annuity Factor at 15% = $1.4 billion (very roughly). Terminal Value (Gordon Growth Model) = $268.5M * (1+0.02)/(0.15-0.02) = $2.14 billion. Total Equity Value = PV of cash flows + Terminal Value = $3.54 billion. With a 5% market share scenario: Present Value of Cash Flows for first 10 years: $1.3425B * Annuity Factor at 15% = $7 billion (again, very roughly). Terminal Value = $1.3425B * (1+0.02)/(0.15-0.02) = $10.7 billion. Total Equity Value = $17.7 billion. Market Multiples: If we use industry multiples (PE ratios for biotech can be very high, especially for novel treatments), with a PE ratio of 20-30 for a company with significant growth potential, the valuation based on earnings from BP1001-A alone would range from: 1% Market Share: $5.37 billion (20 * $268.5M) to $8.055 billion (30 * $268.5M). 5% Market Share: $26.85 billion (20 * $1.3425B) to $40.275 billion (30 * $1.3425B). Fair Valuation: Given these speculative numbers, a fair valuation for BPTH based solely on BP1001-A's potential would be somewhere in the middle of these ranges, adjusted for the company's current financials, other pipeline drugs, and market conditions. Considering the above, a conservative estimate might place BPTH's valuation in the range of $3 billion to $10 billion, depending on market penetration optimism, with the understanding that this is highly speculative and subject to countless variables including regulatory approval, actual market acceptance, and competitive landscape. CONCLUSION & TA: This simply means, IF(!) this drug is succesfull the market cap of this company would significantly rise. Currently we're sitting at a 5.43 million market cap (at close, so lower now), thus its a 100 to 1000x potential or it drops to zero. Last note, price needs to stay above $1 to stay compliant with Nasdaq rules or else there could be an inverse stock split 2 to 1 for example or they face delisting by the end of Q3 2025. I'm not too worried because this is the same as SEALSQ faced before it 10x'd in the last few weeks. TA wise: we're retesting previous resistance and the bull market support band. Chart has been down only for years, capitulation after capitulation thus chance of a rebound should be there. I grabbed a small allocation to sit out for 2025, if the clinical trials are successful, we'll in for a big bull market. If not succesfull, we'll likely lose our money. A very decent risk / reward ratio of you invest an amount you can afford to lose and not more than 5% of your portfolio. This is one of my low cap stock picks, next to LAES (10x since entry) and MOBX (entry last week, flat pa for now). I will be scouting for more but for now, happy holidays!
NASDAQ:BPTHLong
by cryptobullethbtcxlm
Micron Technology ($MU): Breaking Resistance or Building Moment "Undervalued tech stocks are like treasure maps—the trick is knowing where the 'X' marks the breakout. Let’s see where NASDAQ:MU might lead us." Valuation Insight: "Micron Technology ( NASDAQ:MU ) is trading at $87.50, with valuation metrics that scream potential: P/E Ratio: 10.5—well below industry averages. P/B Ratio: 1.7—value investors, take note. EV/Revenue Ratio: 3.5—a discount on future growth." Key Resistance Levels to Watch: $97.18 – The First Test 🎯 "This level marks the first hurdle for $MU. A breakout above could indicate momentum building toward a bullish trend." $118.54 – The Big Break ⚡ "Crossing this level would confirm renewed bullish sentiment. Look for strong volume as a signal for sustained movement." $181.66 – The Bullish Peak 🏔️ "While distant, this historical high serves as a long-term target for investors betting on sustained industry growth." Growth Catalysts: AI and 5G Demand: DRAM and NAND memory are critical for emerging technologies. Institutional Activity: Dark pool orders and market-on-close volume indicate increased interest from big players. Risks to Watch: Cyclical Nature: Overproduction or slowing demand could impact prices. Macroeconomic Headwinds: Higher interest rates might dampen near-term spending in tech. Conclusion: " NASDAQ:MU is undervalued and approaching critical levels—$97.18, $118.54, and $181.66—that could define its path forward. Keep these zones on your radar and watch for volume to validate potential moves."
NASDAQ:MULong
by DCAChampion
$FOUR x your portfolio with this buyKey Stats: Market Cap: $9.3 billion P/E Ratio: 54.9 Revenue (2023): $2.56 billion, a 28.65% increase from 2022 Earnings (2023): $86.2 million, a 14.78% increase from 2022 Next Earnings Date: March 4, 2025 Technical Reasons for Bullish Outlook: Bullish Breakout: The stock has recently broken above a key resistance level indicating strong upward momentum. Strong Uptrend: The 50-day moving average is trending above the 200-day moving average, signalling sustained bullish momentum. Positive RSI: The Relative Strength Index (RSI) is above 70, suggesting strong buying pressure. Fundamental Reasons for Bullish Outlook: Undervalued Stock: Shift4 Payments is valued conservatively compared to industry peers, indicating potential for price appreciation. Robust Revenue Growth: The company reported a 28.65% increase in revenue for 2023, reflecting strong business performance and market demand. Analyst Upgrades: Recent analyst reports have revised price targets upward, reflecting increased confidence in the company's future performance. Potential Paths to Profit: Option 1 - Buy Shares Option 2 - Buy LEAPs. Sell the options when the stock approaches the price target. Disclaimer: We are not a brokerage or investment firm. We do not offer financial advice or investment advice and/or signals. This is not certified financial education. We offer access to the daily thought process of an individual and his experiences. We do not offer refunds. All sales are final. Please LIKE, FOLLOW, SHARE, and COMMENT if you enjoy this idea! Also, share your ideas and charts in the comments section below! This is the best way to keep this signal relevant, keep the content free, and allow the idea to reach as many people as possible.
NYSE:FOURLong
by ChartVZN
Reconsider Your Position: MSTR Faces Significant Volatility Ahea - Recent Performance: MicroStrategy has seen its stock price crash approximately 45% from prior highs of $548 to around $300, aligning closely with Bitcoin's erratic behavior. This substantial drop raises questions about the company's future, viability, and its heavily criticized Bitcoin accumulation strategy. The stock's volatility underscores its correlation with cryptocurrency market fluctuations, making it essential for investors to keep track of Bitcoin trends. - Key Insights: Investors should approach MicroStrategy with caution amidst this turbulent phase. The aggressive use of debt to fund Bitcoin purchases raises significant risk concerns, as continued declines in Bitcoin could drastically impact MSTR's share price. The recent lapse in enthusiasm surrounding the company indicates a shift in market sentiment that may prove detrimental unless there's a recovery in Bitcoin prices. - Expert Analysis: Experts appear to be developing a bearish outlook on MicroStrategy, with growing skepticism regarding its investment strategy and financial stability. The risk has been compared to a potential Ponzi scheme, reinforcing the notion that deeper price drops in Bitcoin could lead to catastrophic consequences for MSTR, driving its stock lower than the current valuation. - Price Targets: For the upcoming week, traders should consider the following: - Next week targets: - T1: $320 - T2: $340 - Stop levels: - S1: $290 - S2: $250 - News Impact: Recent speculation that MicroStrategy may suspend Bitcoin acquisitions could weigh negatively on its market momentum. Potential restrictions on share transactions or debt financing could further strain the company's operational strategy and market positioning. Observations on Bitcoin's pricing dynamics will be crucial as MicroStrategy navigates this volatile landscape; thus, investors should stay informed on developments to align their strategies with market conditions. In conclusion, MicroStrategy presents a precarious investment landscape primarily dictated by the performance of Bitcoin. Given the inherent risks involved, thorough evaluation and vigilance are essential when contemplating any trading actions concerning MSTR.
NASDAQ:MSTRLong
by CrowdWisdomTrading
Nvidia poised for potential bullish breakout next week - Recent Performance: Nvidia has exhibited notable volatility in the market, managing to score over 3% gains within the past week. The stock has remained a central focus in the tech sector, demonstrating resilience despite broader market fluctuations. Analysts are now eyeing this volatility, viewing it as a precursor to further movements, especially as the stock approaches critical resistance levels. - Key Insights: Investors should consider Nvidia as a strong buy opportunity, particularly due to its ability to hold above crucial price thresholds. A breakout beyond the resistance range of $136 to $137 could catalyze a more significant upward trend. The continued strength in the AI sector serves as a major growth driver, underscoring Nvidia's potential in a rapidly evolving technology landscape. - Expert Analysis: The market sentiment surrounding Nvidia is overwhelmingly optimistic. Analysts agree on the high probability of a breakout, which if achieved, would mark a bullish shift for the stock. They stress that maintaining prices above key support levels is essential for sustaining positive momentum, as Nvidia continues to lead in the AI space amid rising market demand. - Price Targets: Based on current market analysis, the price targets for next week are as follows: - Next week targets: T1 = 138, T2 = 144 - Stop levels: S1 = 132, S2 = 125 - News Impact: Nvidia has recently gained attention due to its strategic partnerships aimed at enhancing AI capabilities, including significant collaborations in India. The company anticipates remarkable revenue growth driven by the demand for its AI-based products, forecasting a 79% increase. The introduction of the new Blackwell AI processor has further excited analysts and investors alike, reinforcing Nvidia's strong market position. Overall, solid performance metrics, expert optimism, significant support and resistance levels, and important partnerships collectively suggest Nvidia is well-positioned for growth in the upcoming week.
NASDAQ:NVDALong
by CrowdWisdomTrading
Aiming for Bullish Momentum: PLTR Set for Next WeekRecent Performance: Palantir Technologies (PLTR) has seen a notable rise in its stock price following its inclusion in the NASDAQ 100. The market has reacted positively, reflecting strong investor interest underpinned by solid earnings driven by government contracts and advancements in AI. Analysts predict potential hurdles at the resistance levels of $82 to $85, while a key support level around $75 serves as a safety net against drastic declines. - Key Insights: Investors should pay attention to the potential bullish momentum as PLTR approaches critical resistance levels. The rapid growth in government contracts coupled with strategic partnerships positions the company well for continued expansion, especially in the defense sector. However, the mixed sentiments on valuation sustainability suggest a need for cautious trading and monitoring market movements closely. - Expert Analysis: Market sentiment on PLTR is generally optimistic despite the polarized views from analysts. While some voices express concerns regarding valuation, the prevailing sentiment leans towards confidence in Palantir's AI capabilities and government initiatives. This mixed but predominantly bullish sentiment could drive price movements in the upcoming week. - Price Targets: Based on professional traders' insights: Next week targets: T1 = 84, T2 = 87. Stop levels: S1 = 75, S2 = 73. This positioning allows for a safeguarded long strategy while targeting upside potential in line with recent market performance. - News Impact: Recent strategic moves, such as the partnership with Booz Allen Hamilton, highlight Palantir's ongoing efforts to secure more government contracts. The impressive 40% year-over-year increase in US government revenue further underscores this trend, alongside the FedRAMP High authorization for federal cloud services. These developments not only bolster Palantir's credibility but also enhance growth prospects, positively influencing market sentiment.
NASDAQ:PLTRLong
by CrowdWisdomTrading
Reacting to Market Volatility: Visa Trading Insights for Next We- Recent Performance: Visa has experienced fluctuations along with the broader market in recent weeks. The current price stands at 317.71, reflecting the overall market volatility driven by concerns around interest rates and economic indicators. Despite the turmoil, Visa's resilience and established market position suggest a strong foundation for future performance. - Key Insights: Investors should closely monitor Visa's stock as potential buying opportunities may arise if broader market sentiment stabilizes. Given the current price range, Visa is well-positioned to benefit if the market rebounds, particularly through any positive movements in consumer spending trends. - Expert Analysis: Market sentiment is mixed, with analysts advising caution before committing to new positions. Although some sectors, especially technology, show promise, the prevailing negativity could lead to short-term setbacks. Experts recommend watching key levels for signs of a bottom formation that could favor Visa's stock. - Price Targets: Next week targets are set at T1 = 330, T2 = 345. Stop levels are established at S1 = 310, S2 = 295, - News Impact: The Federal Reserve's recent interest rate cuts and upcoming economic data releases, particularly those concerning consumer spending, are pivotal for Visa. Market participants should remain vigilant for any changes in economic outlook that could impact transaction volumes and overall revenue growth for Visa.
NYSE:VLong
by CrowdWisdomTrading
Invest in Tesla for a Potential Bounce Back Next Week Tesla has recently faced significant volatility, retreating sharply from previous highs around $488 to a current level of $421.06. This price movement reflects persistent selling pressure and profit-taking among investors, with the stock closing near critical support levels. The broader tech sector's mixed performance further complicates investor sentiment, as stocks like Apple and Amazon also experience fluctuations. Amid this backdrop, many analysts remain optimistic about Tesla's potential, particularly due to advancements in low-cost electric vehicles and its autonomous driving technology. Investors should note certain actionable insights: the current support sits at $419 and $415, and a breach of these levels could signal further declines towards $400. Conversely, watch resistance levels at $438 and $449.50, as a breakout above these could indicate a potential bullish reversal. As sentiments fluctuate, Tesla's recent recall concerning nearly 700,000 vehicles due to a tire pressure monitoring issue has introduced additional volatility, impacting short-term trading behavior and investor confidence. Expert opinions appear divided on Tesla's valuation with some, like Ron Baron, foreseeing a potential market cap of $5 trillion over the next decade based on long-term advancements in EV technology. On the other hand, caution arises from concerns over the stock’s current overvaluation in a bearish market environment. Traders must keep a keen eye on Tesla's price movements and broader market conditions as both contribute to the overall sentiment and trading strategies. For next week, price targets based on professional traders' insights are set as follows: Next week targets are T1 at $430 and T2 at $440, suggesting a potential recover if bullish momentum develops. For managing downside risk, stop levels are set at S1 at $415 and S2 at $410, ensuring that the strategy is aligned with market fluctuations. The recall announcement has generated mixed reactions; while providing needed updates, it raises investor concerns regarding operational integrity and potential long-term impacts on market confidence. Additionally, Tesla’s ongoing efforts to develop a new autonomous driving platform and production of low-cost electric vehicles position it as a key player in the evolving EV market landscape. Investors will need to monitor these developments closely to assess their effects on stock performance and market sentiment.
NASDAQ:TSLALong
by CrowdWisdomTrading
The $X your mum warns you aboutKey Stats Dividend Yield: 0.66% (Not exactly a retirement dream here) Market Cap: $6.79B Next Earnings Date: January 30, 2025 Technical Reasons for Decline 1️⃣ Head and Shoulders Breakdown: X recently completed a textbook head-and-shoulders pattern, breaking below $26.50 support with high volume. The next significant support zone sits near $22.00. 2️⃣ Bearish Moving Averages: The 50-day MA is crossing below the 200-day MA (death cross), often signaling more downside. 3️⃣ RSI Deterioration: Momentum is fading, with RSI hovering near 38, showing weak buying interest and no signs of a reversal. Fundamental Reasons for Decline 1️⃣ Falling Steel Prices: Declining global steel demand due to slowing construction and manufacturing activity weighs heavily on X’s revenue projections. 2️⃣ CapEx Concerns: High capital expenditure commitments ($2.5B planned for 2024) will pressure cash flow, especially in a downturn. 3️⃣ Macro Headwinds: The Federal Reserve’s hawkish stance and potential economic slowdown spell trouble for cyclical industries like steel. Potential Paths to Profit Option 1 (Low Risk): Sell short shares of X or use inverse ETFs if available. Option 2 (Moderate Risk): Buy February 2025 $25 strike puts and aim for a 20%-100% profit. Disclaimer: We are not a brokerage or investment firm. We do not offer financial advice or investment advice and/or signals. This is not certified financial education. We offer access to the daily thought process of an individual and his experiences. We do not offer refunds. All sales are final. Please LIKE, FOLLOW, SHARE, and COMMENT if you enjoy this idea! Also share your ideas and charts in the comments section below! This is the best way to keep this signal relevant, keep the content free, and allow the idea to reach as many people as possible.
NYSE:XShort
by ChartVZN